US2023012463A1PendingUtilityA1
Cyclic sulfamide compounds and methods of using same
Est. expiryMar 2, 2037(~10.6 yrs left)· nominal 20-yr term from priority
Inventors:William W. Turner, Jr.Leping LiSimon Nicolas HaydarMark G. BuresRoopa RaiSamson FrancisLee D. Arnold
C07D 417/04C07D 417/14A61P 31/12C07D 417/10C07D 285/16A61P 31/20A61K 31/549
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides, in part, cyclic sulfamide compounds, and pharmaceutical compositions thereof, useful as modulators of Hepatitis B (HBV) core protein, and methods of treating Hepatitis B (HBV) infection.
Claims
exact text as granted — not AI-modified1 .- 24 . (canceled)
25 . A compound:
or a pharmaceutically acceptable salt thereof.
26 . A pharmaceutical composition comprising a compound:
or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipient.
27 . A method of treating HBV infection in a subject in need thereof, comprising administering to the subject a compound:
or a pharmaceutically acceptable salt thereof.Join the waitlist — get patent alerts
Track US2023012463A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.